Matches in Wikidata for { <http://www.wikidata.org/entity/Q63841214> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q63841214 description "clinical trial" @default.
- Q63841214 description "ensayu clínicu" @default.
- Q63841214 description "klinisch onderzoek" @default.
- Q63841214 description "клінічне випробування" @default.
- Q63841214 name "Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer" @default.
- Q63841214 type Item @default.
- Q63841214 label "Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer" @default.
- Q63841214 prefLabel "Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer" @default.
- Q63841214 P1132 Q63841214-CD5B5F87-2AA5-4794-8C5C-E564ABB9359A @default.
- Q63841214 P1476 Q63841214-1021F377-D9CE-4BC5-BAD5-3C610B94CB8B @default.
- Q63841214 P2899 Q63841214-3BC0CCBD-2F0B-4074-93D8-717FE53769B0 @default.
- Q63841214 P3098 Q63841214-9A07FAE2-5D48-40C4-89C7-A43DACA87101 @default.
- Q63841214 P31 Q63841214-A4055D77-A21E-4FA0-A8BC-6458330F61B1 @default.
- Q63841214 P4844 Q63841214-DF583859-5A54-459F-923E-495019C30D66 @default.
- Q63841214 P580 Q63841214-B71A745C-EF77-4575-B80F-72E2961E7ACC @default.
- Q63841214 P582 Q63841214-321F1E61-DFC3-4BAF-BBE0-E3B5CB955AF2 @default.
- Q63841214 P6099 Q63841214-F59B600D-128E-4972-AB93-D1E6CE25ADCB @default.
- Q63841214 P6153 Q63841214-5482390F-3C43-4C59-BEAA-8ABA8C6663D5 @default.
- Q63841214 P6153 Q63841214-66FB7E14-8C07-4BF5-A21F-D378596C25B6 @default.
- Q63841214 P8363 Q63841214-FDD31E68-A063-4911-A756-BE31B8FC7794 @default.
- Q63841214 P859 Q63841214-F57AC1D4-7B24-4352-8165-496F3776CDCF @default.
- Q63841214 P1132 "+27" @default.
- Q63841214 P1476 "A Phase II Study of Weekly Abraxane for Patients With Advanced NSCLC With EGFR Mutations or With Durable Response to an EGFR Tyrosine Kinase Inhibitor Following Front Line Therapy With EGFR Tyrosine Kinase Inhibitors" @default.
- Q63841214 P2899 "+18" @default.
- Q63841214 P3098 "NCT01620190" @default.
- Q63841214 P31 Q30612 @default.
- Q63841214 P4844 Q423762 @default.
- Q63841214 P580 "2012-11-06T00:00:00Z" @default.
- Q63841214 P582 "2021-04-20T00:00:00Z" @default.
- Q63841214 P6099 Q42824440 @default.
- Q63841214 P6153 Q219563 @default.
- Q63841214 P6153 Q5611154 @default.
- Q63841214 P8363 Q78089383 @default.
- Q63841214 P859 Q219563 @default.